IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Catalent Sells Osny Unit

11:17 AM MDT | April 10, 2009

Catalent Pharma Solutions (Somerset, NJ), a contract manufacturer and pharmaceutical services company, says it has sold its Osny, France oral drug manufacturing business to Bavaria Industriekapital (Munich), a holding company that buys, restructures, and re-sells firms in Europe. Terms were not disclosed. Bavaria Industriekapital expects to retain all employees associated with the purchase and to continue to serve the business’s existing customers, Catalent says. The business will become known as Osny Pharma after the acquisition closes, Catalent says. Osny...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa